Table 3.
Vascular, bleeding, and central nervous system complications
Total (n = 25) | Survivors (n = 11) | Non-survivors (n = 14) | P | |
---|---|---|---|---|
Vascular complications | ||||
Surgery repair after cannulation | 8 (32%) | 5 (46%) | 3 (21%) | 0.201 |
Ischaemic leg | 7 (28%) | 5 (46%) | 2 (14%) | 0.085 |
Ischaemic leg requiring intervention | 6 (24%) | 5 (46%) | 1 (7%) | 0.084 |
Bleeding complications | ||||
BARC bleeding criteria⁎ | ||||
Type 0 — no bleeding | 10 (40%) | 2 (18%) | 8 (57%) | |
Type 1 — bleeding not actionable | 5 (20%) | 4 (36%) | 1 (7%) | |
Type 2 | 1 (4%) | 0 | 1 (7%) | |
Type 3a | 6 (24%) | 4 (36%) | 2 (14%) | |
Type 3b | 3 (12%) | 1 (9%) | 2 (14%) | |
Type 5 | 3 (12%) | 3 (21%) | ||
Packed red blood cells during run, median (IQR) | 2 (0-8) | 3 (1-8) | 1 (0-8) | 0.501 |
Central nervous system complications | 4 (16%) | |||
Ischaemic stroke | 2 (8%) | 2 (14%) | ||
Cerebral bleeding | 2 (8%) | 2 (14%) | ||
Spinal cord infarction | 1 (4%) | 1 (9%) | ||
BARC = Bleeding Academic Research |
Consortium; IQR = interquartile range.
Mehran et al.10